Clinical Trials Directory

Trials / Completed

CompletedNCT02665728

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Braintree Laboratories · Industry
Sex
All
Age
12 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety and efficacy of BLI400 laxative in constipated adolescent subjects.

Conditions

Interventions

TypeNameDescription
DRUGBLI400 Laxative

Timeline

Start date
2015-12-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2016-01-28
Last updated
2020-06-26
Results posted
2020-06-26

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02665728. Inclusion in this directory is not an endorsement.

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects (NCT02665728) · Clinical Trials Directory